• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经节苷脂GD3合酶(GD3S),一种新型癌症药物靶点。

Ganglioside GD3 synthase (GD3S), a novel cancer drug target.

作者信息

Liu Jinyi, Zheng Xiangjin, Pang Xiaocong, Li Li, Wang Jinhua, Yang Cui, Du Guanhua

机构信息

Ethnic Drug Screening & Pharmacology Center, Key Laboratory of Chemistry in Ethnic Medicinal Resources, State Ethnic Affairs Commission & Ministry of Education, Yunnan Minzu University, Kunming 650500, China.

Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100050, China.

出版信息

Acta Pharm Sin B. 2018 Sep;8(5):713-720. doi: 10.1016/j.apsb.2018.07.009. Epub 2018 Jul 25.

DOI:10.1016/j.apsb.2018.07.009
PMID:30245960
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6147802/
Abstract

Gangliosides are a class of important glycosphingolipids containing sialic acid that are widely distributed on the outer surface of cells and are abundantly distributed in brain tissue. Disialoganglioside with three glycosyl groups (GD3) and disialoganglioside with two glycosyl groups (GD2) are markedly increased in pathological conditions such as cancers and neurodegenerative diseases. GD3 and GD2 were found to play important roles in cancers by mediating cell proliferation, migration, invasion, adhesion, angiogenesis and in preventing immunosuppression of tumors. GD3 synthase (GD3S) is the regulatory enzyme of GD3 and GD2 synthesis, and is important in tumorigenesis and the development of cancers. The study of GD3S as a drug target may be of great significance for the discovery of new drugs for cancer treatment. This review will describe the gangliosides and their roles in physiological and pathological conditions; the roles of GD3 and GD2 in cancers; the expression, functions and mechanisms of GD3S, and its potential as a drug target in cancers.

摘要

神经节苷脂是一类含有唾液酸的重要糖鞘脂,广泛分布于细胞外表面,在脑组织中含量丰富。具有三个糖基的双唾液酸神经节苷脂(GD3)和具有两个糖基的双唾液酸神经节苷脂(GD2)在癌症和神经退行性疾病等病理状况下显著增加。研究发现,GD3和GD2通过介导细胞增殖、迁移、侵袭、黏附、血管生成以及防止肿瘤免疫抑制,在癌症中发挥重要作用。GD3合酶(GD3S)是GD3和GD2合成的调节酶,在肿瘤发生和癌症发展中起重要作用。将GD3S作为药物靶点进行研究可能对发现癌症治疗新药具有重要意义。本文综述将描述神经节苷脂及其在生理和病理状况下的作用;GD3和GD2在癌症中的作用;GD3S的表达、功能和机制,以及其作为癌症药物靶点的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604b/6147802/45ec93f626c6/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604b/6147802/af825141795d/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604b/6147802/2e6f0d42257c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604b/6147802/a899ac91e166/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604b/6147802/45ec93f626c6/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604b/6147802/af825141795d/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604b/6147802/2e6f0d42257c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604b/6147802/a899ac91e166/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604b/6147802/45ec93f626c6/gr3.jpg

相似文献

1
Ganglioside GD3 synthase (GD3S), a novel cancer drug target.神经节苷脂GD3合酶(GD3S),一种新型癌症药物靶点。
Acta Pharm Sin B. 2018 Sep;8(5):713-720. doi: 10.1016/j.apsb.2018.07.009. Epub 2018 Jul 25.
2
Disialyl GD2 ganglioside suppresses ICAM-1-mediated invasiveness in human breast cancer MDA-MB231 cells.双唾液酸神经节苷脂GD2抑制人乳腺癌MDA-MB231细胞中ICAM-1介导的侵袭性。
Int J Biol Sci. 2017 Feb 12;13(3):265-275. doi: 10.7150/ijbs.16903. eCollection 2017.
3
The biological role and immunotherapy of gangliosides and GD3 synthase in cancers.神经节苷脂和GD3合酶在癌症中的生物学作用及免疫治疗
Front Cell Dev Biol. 2023 Feb 7;11:1076862. doi: 10.3389/fcell.2023.1076862. eCollection 2023.
4
Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype.神经节苷脂GD3和GD2与生长因子受体的相互作用维持乳腺癌干细胞表型。
Oncotarget. 2017 Jul 18;8(29):47454-47473. doi: 10.18632/oncotarget.17665.
5
Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2.神经节苷脂 GD3/GD2 增强人神经胶质瘤细胞的恶性特性。
Int J Oncol. 2018 Apr;52(4):1255-1266. doi: 10.3892/ijo.2018.4266. Epub 2018 Feb 7.
6
Ganglioside GD3 is up-regulated in microglia and regulates phagocytosis following global cerebral ischemia.神经节苷脂 GD3 在小胶质细胞中上调,并调节全脑缺血后的吞噬作用。
J Neurochem. 2021 Aug;158(3):737-752. doi: 10.1111/jnc.15455. Epub 2021 Jul 7.
7
The ceramide moiety of disialoganglioside (GD3) is essential for GD3 recognition by the sialic acid-binding lectin SIGLEC7 on the cell surface.神经节苷脂 GD3 的神经酰胺部分对于细胞表面唾液酸结合凝集素 SIGLEC7 识别 GD3 是必需的。
J Biol Chem. 2019 Jul 12;294(28):10833-10845. doi: 10.1074/jbc.RA118.007083. Epub 2019 May 28.
8
Characterization of expression and prognostic implications of GD2 and GD3 synthase in canine histiocytic sarcoma.鉴定犬组织细胞肉瘤中 GD2 和 GD3 合酶的表达特征及其预后意义。
Vet Immunol Immunopathol. 2023 May;259:110594. doi: 10.1016/j.vetimm.2023.110594. Epub 2023 Apr 10.
9
Glycosphingolipids in human embryonic stem cells and breast cancer stem cells, and potential cancer therapy strategies based on their structures and functions.人胚胎干细胞和乳腺癌干细胞中的糖鞘脂及其结构与功能与基于其结构与功能的潜在癌症治疗策略。
Glycoconj J. 2022 Apr;39(2):177-195. doi: 10.1007/s10719-021-10032-w. Epub 2022 Mar 10.
10
GD2 and its biosynthetic enzyme GD3 synthase promote tumorigenesis in prostate cancer by regulating cancer stem cell behavior.GD2 及其生物合成酶 GD3 合酶通过调节肿瘤干细胞行为促进前列腺癌的发生。
Sci Rep. 2024 Jun 12;14(1):13523. doi: 10.1038/s41598-024-60052-3.

引用本文的文献

1
Novel Application of Ion Mobility Mass Spectrometry Reveals Complex Ganglioside Landscape in Diffuse Astrocytoma Peritumoral Regions.离子淌度质谱的新应用揭示弥漫性星形细胞瘤瘤周区域复杂的神经节苷脂图谱。
Int J Mol Sci. 2025 Aug 29;26(17):8433. doi: 10.3390/ijms26178433.
2
Insights into Siglec-7 Binding to Gangliosides: NMR Protein Assignment and the Impact of Ligand Flexibility.对唾液酸结合免疫球蛋白样凝集素-7与神经节苷脂结合的深入研究:核磁共振蛋白质归属及配体灵活性的影响
Adv Sci (Weinh). 2025 Jun;12(21):e2415782. doi: 10.1002/advs.202415782. Epub 2025 Apr 26.
3
Cellular Epigenetic Targets and Epidrugs in Breast Cancer Therapy: Mechanisms, Challenges, and Future Perspectives.

本文引用的文献

1
Dinutuximab for the treatment of pediatric patients with neuroblastoma.地努图希单抗用于治疗小儿神经母细胞瘤患者。
Drugs Today (Barc). 2017 Sep;53(9):469-476. doi: 10.1358/dot.2017.53.9.2693023.
2
[Advanced progress of main pharmacology activities of triptolide].雷公藤甲素主要药理活性的研究进展
Zhongguo Zhong Yao Za Zhi. 2017 Jul;42(14):2655-2658. doi: 10.19540/j.cnki.cjcmm.20170609.011.
3
Expression of Disialoganglioside (GD2) in Neuroblastic Tumors: A Prognostic Value for Patients Treated With Anti-GD2 Immunotherapy.
乳腺癌治疗中的细胞表观遗传靶点与表观遗传药物:作用机制、挑战及未来展望
Pharmaceuticals (Basel). 2025 Feb 3;18(2):207. doi: 10.3390/ph18020207.
4
When a negative (charge) is not a positive: sialylation and its role in cancer mechanics and progression.当负(电荷)并非正性时:唾液酸化及其在癌症机制与进展中的作用
Front Oncol. 2024 Nov 19;14:1487306. doi: 10.3389/fonc.2024.1487306. eCollection 2024.
5
Leveraging altered lipid metabolism in treating B cell malignancies.利用改变的脂质代谢治疗 B 细胞恶性肿瘤。
Prog Lipid Res. 2024 Jul;95:101288. doi: 10.1016/j.plipres.2024.101288. Epub 2024 Jul 2.
6
Glycosphingolipids in Osteoarthritis and Cartilage-Regeneration Therapy: Mechanisms and Therapeutic Prospects Based on a Narrative Review of the Literature.《基于文献综述的叙述性评价:骨关节炎和软骨再生治疗中的糖脂:机制与治疗前景》
Int J Mol Sci. 2024 Apr 30;25(9):4890. doi: 10.3390/ijms25094890.
7
Advances in Mass Spectrometry of Gangliosides Expressed in Brain Cancers.脑癌中表达的神经节苷脂的质谱分析进展
Int J Mol Sci. 2024 Jan 22;25(2):1335. doi: 10.3390/ijms25021335.
8
The Potential of Siglecs and Sialic Acids as Biomarkers and Therapeutic Targets in Tumor Immunotherapy.Siglecs和唾液酸作为肿瘤免疫治疗生物标志物和治疗靶点的潜力
Cancers (Basel). 2024 Jan 10;16(2):289. doi: 10.3390/cancers16020289.
9
A modular chemoenzymatic cascade strategy for the structure-customized assembly of ganglioside analogs.一种用于神经节苷脂类似物结构定制组装的模块化化学酶级联策略。
Commun Chem. 2024 Jan 18;7(1):17. doi: 10.1038/s42004-024-01102-9.
10
RREB1 regulates neuronal proteostasis and the microtubule network.RREB1 调节神经元的蛋白质平衡和微管网络。
Sci Adv. 2024 Jan 12;10(2):eadh3929. doi: 10.1126/sciadv.adh3929. Epub 2024 Jan 10.
双唾液酸神经节苷脂(GD2)在神经母细胞瘤中的表达:抗GD2免疫治疗患者的预后价值
Pediatr Dev Pathol. 2018 Jul-Aug;21(4):355-362. doi: 10.1177/1093526617723972. Epub 2017 Oct 25.
4
Effect of the Natural Product Triptolide on Pancreatic Cancer: A Systematic Review of Preclinical Studies.天然产物雷公藤甲素对胰腺癌的影响:临床前研究的系统评价
Front Pharmacol. 2017 Aug 25;8:490. doi: 10.3389/fphar.2017.00490. eCollection 2017.
5
Anti-GD2 immunotherapy for neuroblastoma.用于神经母细胞瘤的抗GD2免疫疗法。
Expert Rev Anticancer Ther. 2017 Oct;17(10):889-904. doi: 10.1080/14737140.2017.1364995. Epub 2017 Aug 14.
6
Triptolide Inhibits the AR Signaling Pathway to Suppress the Proliferation of Enzalutamide Resistant Prostate Cancer Cells.雷公藤甲素抑制雄激素受体信号通路以抑制恩杂鲁胺耐药前列腺癌细胞的增殖。
Theranostics. 2017 Apr 20;7(7):1914-1927. doi: 10.7150/thno.17852. eCollection 2017.
7
Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype.神经节苷脂GD3和GD2与生长因子受体的相互作用维持乳腺癌干细胞表型。
Oncotarget. 2017 Jul 18;8(29):47454-47473. doi: 10.18632/oncotarget.17665.
8
Safety and efficacy of the antiganglioside GD3 antibody ecromeximab (KW2871) combined with high-dose interferon-α2b in patients with metastatic melanoma.抗神经节苷脂GD3抗体ecromeximab(KW2871)联合大剂量干扰素-α2b治疗转移性黑色素瘤患者的安全性和有效性。
Melanoma Res. 2017 Aug;27(4):342-350. doi: 10.1097/CMR.0000000000000353.
9
[The role of FOXO3a-Bim signaling in triptolide induced bladder cancer T24 cells apoptosis].[FOXO3a-Bim信号通路在雷公藤甲素诱导膀胱癌T24细胞凋亡中的作用]
Zhonghua Yi Xue Za Zhi. 2017 Apr 18;97(15):1187-1190. doi: 10.3760/cma.j.issn.0376-2491.2017.15.016.
10
GD2 expression in breast cancer.GD2在乳腺癌中的表达。
Oncotarget. 2017 May 9;8(19):31592-31600. doi: 10.18632/oncotarget.16363.